by EmpathiCSubstanceS | Sep 21, 2018 | PTSD
As final trials move to establish MDMA-assisted psychotherapy as a legal and legitimate clinical treatment, a new study has recently been published demonstrating the results of the world’s first clinical trial for another, albeit more controversial, application...
by EmpathiCSubstanceS | Sep 21, 2018 | Anxiety
When humans take the drug MDMA, versions of which are known as molly or ecstasy, they commonly feel very happy, extraverted, and particularly interested in physical touch. A group of scientists recently wondered whether this drug might have a similar effect on other...
by EmpathiCSubstanceS | Sep 1, 2018 | Anxiety, Cannabis Marijuana, Chronic Pain, Depression, Iboga, Kambo, MDMA Sassafras Molly, Neuropathy, OCD
Dennis van der Meijden isn’t aiming to see the face of God, feel one with the cosmos, grasp the hidden reality of time and space, or embark on a sacred journey. What the Dutch graphic designer, producer, and rapper (under the professional name Terilekst) wants—and...
by EmpathiCSubstanceS | Aug 27, 2018 | Anxiety
Why psychedelic drugs could transform how we treat depression and mental illness? The first time I tried ayahuasca, a plant concoction containing the natural hallucinogen DMT, I remember thinking: “Just let go. Whatever happens, just let go.” Eventually, I did let go,...
by EmpathiCSubstanceS | Jul 20, 2018 | Addiction
The psychedelic drug psilocybin (the active ingredient in “magic mushrooms”) may produce lasting, positive changes in personality, new research finds. People who took the drug showed increases in the key personality dimension of openness — being amenable to new ideas,...
